Acumen Pharmaceuticals In... (ABOS)
NASDAQ: ABOS
· Real-Time Price · USD
1.42
0.02 (1.43%)
At close: Aug 15, 2025, 3:59 PM
1.44
1.41%
After-hours: Aug 15, 2025, 04:10 PM EDT
Acumen Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 178K | 178K | 178K | 290K | 290K | 290K | 290K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.44M | 2.17M | 2.32M |
Cost of Revenue | 179K | 224K | 223K | 173K | 168K | 176K | 184K | 194K | 198K | 184K | 169K | 123K | 80K | 2.29M | 4.79M | 5.81M | 8.8M | 8.48M |
Gross Profit | -1K | -46K | -45K | -173K | -168K | -176K | -184K | -194K | -198K | -184K | -169K | -123K | -80K | -2.29M | -4.79M | -4.38M | -6.64M | -6.16M |
Operating Income | -143.98M | -126.61M | -114.02M | -92.91M | -76.68M | -65.78M | -61.14M | -56.9M | -52.23M | -49.16M | -45.24M | -39.4M | -31.97M | -25M | -19.58M | -12.51M | -11.06M | -9.66M |
Interest Income | 10.98M | 12.78M | 14.32M | 15.28M | 14.9M | 12.96M | 10.79M | 8.23M | 5.77M | 4.15M | 2.39M | 1.04M | 412K | 156K | 84K | 45K | 8K | 4K |
Pretax Income | -136.66M | -116.25M | -102.33M | -81.67M | -64.86M | -55.94M | -52.37M | -48.74M | -46.49M | -45.03M | -42.86M | -38.34M | -31.53M | -82.74M | -100.61M | -93.01M | -91.6M | -32.28M |
Net Income | -136.66M | -116.25M | -102.33M | -81.67M | -64.86M | -55.94M | -50.54M | -47.91M | -45M | -43.28M | -42.86M | -37.34M | -31.19M | -82.66M | -100.61M | -93.01M | -91.6M | -32.28M |
Selling & General & Admin | 19.77M | 20M | 20.22M | 20.38M | 20.23M | 19.72M | 18.82M | 17.13M | 15.33M | 14.08M | 12.88M | 12.12M | 11.19M | 9.29M | 7.28M | 5.18M | 3.27M | 2.34M |
Research & Development | 124.21M | 106.61M | 93.8M | 72.52M | 56.45M | 46.05M | 42.32M | 39.77M | 36.9M | 35.09M | 32.36M | 27.29M | 20.78M | 15.71M | 12.3M | 7.66M | 8.85M | 8.53M |
Other Expenses | n/a | n/a | n/a | -39K | -39K | -55K | -59K | -30K | -32K | -16K | -11K | 3K | 24K | 43K | 51K | 1.15M | 1.14M | 1.12M |
Operating Expenses | 143.98M | 126.61M | 114.02M | 92.87M | 76.64M | 65.74M | 61.1M | 56.9M | 52.23M | 49.16M | 45.24M | 39.4M | 31.97M | 25M | 19.58M | 13.95M | 12.5M | 11.25M |
Interest Expense | 4.13M | 4.09M | 4.07M | 3.61M | 2.58M | 1.58M | 581K | n/a | n/a | n/a | n/a | n/a | 23K | 23K | 23K | 23K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 143.98M | 126.61M | 114.02M | 92.91M | 76.68M | 65.78M | 61.14M | 56.9M | 52.23M | 49.16M | 45.24M | 39.4M | 31.97M | 25M | 19.58M | 13.95M | 12.5M | 11.25M |
Income Tax Expense | n/a | n/a | -44K | -44K | -84K | -84K | -1.87M | -870K | -1.49M | -1.75M | n/a | -1.06M | -403K | -143K | -66K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 60.57M | 60.53M | 60.01M | 60.08M | 60.08M | 59.81M | 57.91M | 54.23M | 41.03M | 41.03M | 40.86M | 40.5M | 40.5M | 40.47M | 38.27M | 38.27M | 38.65M | 36.99M |
Shares Outstanding (Diluted) | 60.57M | 60.53M | 60.01M | 60.08M | 60.08M | 59.81M | 58.01M | 54.23M | 41.03M | 41.03M | 40.86M | 40.5M | 40.5M | 40.47M | 38.27M | 38.27M | 38.65M | 36.99M |
EPS (Basic) | -2.28 | -1.94 | -1.71 | -1.37 | -1.11 | -1.05 | -1.03 | -1.09 | -1.1 | -1.06 | -1.05 | -0.93 | -0.78 | -2.13 | -2.64 | -2.45 | -2.43 | -0.91 |
EPS (Diluted) | -2.28 | -1.94 | -1.71 | -1.37 | -1.11 | -1.05 | -1.03 | -1.09 | -1.1 | -1.06 | -1.05 | -0.93 | -0.78 | -2.13 | -2.64 | -2.45 | -2.43 | -0.91 |
EBITDA | -134.24M | -111.98M | -98.08M | -77.89M | -65.23M | -57.3M | -54.73M | -53.09M | -48.42M | -47.27M | -45.19M | -39.32M | -31.88M | -24.91M | -19.54M | -12.51M | -11.07M | -9.66M |
EBIT | -132.53M | -112.16M | -98.26M | -78.06M | -65.36M | -57.44M | -54.87M | -53.2M | -48.54M | -47.34M | -45.24M | 41.66M | 49.1M | 56.07M | 61.48M | -12.51M | -11.07M | -9.66M |
Depreciation & Amortization | 134K | 179K | 178K | 173K | 168K | 176K | 184K | 194K | 198K | 184K | 169K | 123K | 80K | 3.48M | 7.24M | 8.58M | 11.06M | 9.66M |